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Abstract
The wingless-type MMTV integration site family of proteins (WNTs) is highly conserved secreted lipid-modified signaling
molecules that play a variety of pivotal roles in developmental events such as embryogenesis, tissue homeostasis and cell
polarity. Although, of these proteins, WNT4 is known to be involved in genital development in fetuses of mammalian
species, its role is unknown in avian species. Therefore, in this study, we investigated expression profiles, as well as
hormonal and post-transcriptional regulation of WNT4 expression in the reproductive tract of female chickens. Results of
this study demonstrated that WNT4 is most abundant in the stromal and luminal epithelial cells of the isthmus and shell
gland of the oviduct, respectively. WNT4 is also most abundant in the glandular epithelium of the shell gland of the oviduct
of laying hens at 3 h post-ovulation during the laying cycle. In addition, treatment of young chicks with diethylstilbestrol
(DES, a synthetic estrogen agonist) stimulated WNT4 only in the glandular epithelial cells of the isthmus and shell gland of
the oviduct. Moreover, results of our study demonstrated that miR-1786 influences WNT4 expression via specific binding
sites in its 39-UTR. On the other hand, our results also indicate that WNT4 is expressed predominantly in the glandular
epithelium of cancerous ovaries, but not in normal ovaries of hens. Collectively, these results indicate cell-specific expression
of WNT4 in the reproductive tract of chickens and that it likely has crucial roles in development and function of oviduct as
well as initiation of ovarian carcinogenesis in laying hens.
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Introduction
The chicken oviduct is well known as a model for research on
hormone action, including effects of estrogen and progesterone
[1]. Especially, estrogen is known as the hormone responsible for
growth of the yolk and follicle, and the process of calcium
metabolism for formation of the egg shell and the process of
oviposition or laying of the egg [1]. In addition, estrogen has also a
crucial role in the process of the synthesis of egg white proteins in
the oviduct [2]. Furthermore, formation of the tubular glands and
differentiation of the epithelial cells including goblet and ciliated
cells in the chicken oviduct are induced by estrogen [3].
WNT4 is a secretory signaling protein concerned with multiple
processes in organ development including formation of kidney,
mammary gland and adrenal gland, as well as sexual development in
mammals [4]. Of particular note, WNT4 is a key player in the
development and differentiation of the female reproductive system.
In mice, theWnt4 signaling pathway participates in folliculogenesis,
luteogenesis and steroidogenesis of granulosa cells and in the
regulatory processes of stromal cell proliferation and differentiation
for survival and development of embryos within the uterine lumen
[5]. Interestingly, several genes involved in the WNT signal
pathway(s) are regulated by estrogen. In fact, the WNT4-FZD2
signaling pathway is activated by binding of estrogen to estrogen
receptor alpha (ESR1) in the uterus [6] and in somatotrophs that
produce growth hormone in the anterior pituitary gland of rodents
[4]. Furthermore, over-expression of WNT4 leads to the develop-
ment of malignant tumors. Indeed, the elevated expression of
WNT4 is frequently observed in many breast cancer patients which
implies that it’s aberrant expression leads to abnormal cell
proliferation and breast cancer in women [7].
There is little known about the expression or function of WNT4
in the reproductive tract of female chickens. Therefore, the
objectives of this study were to: 1) reveal cell-specific expression
patterns of WNT4 in the chicken oviduct during the reproductive
cycle; 2) determine whether estrogen regulates expression of
WNT4 during development of the chick oviduct; 3) determine
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whether WNT4 expression is mediated through post-transcrip-
tional activity of specific microRNAs and 4) compare the
expression pattern of WNT4 between normal and cancerous
ovaries. Results of the present study provide novel insights into the
WNT4 gene of chickens with respect to cell-specific expression and
hormonal regulation of its expression during oviduct development,
the laying cycle and development of ovarian carcinogenesis in
laying hens.
Results
Expression and localization of WNT4 in the chicken
oviduct
Anatomically, the chicken oviduct consists of four segments: the
infundibulum (site of fertilization), magnum (production of
components of egg-white), isthmus (formation of the shell
membrane) and shell gland (formation of the egg shell). Results
of RT-PCR analysis indicated a high level of WNT4 mRNA
expression in the isthmus and the shell gland as compared with the
infundibulum and the magnum (Figure 1A). Further, quantitative
PCR analysis revealed that WNT4 mRNA levels in the isthmus
and the shell gland were 3.59- and 3.29-fold (P,0.01) greater,
respectively, than for the infundibulum, and its expression
decreased 0.16-fold in the magnum (Figure 1B). To determine
localization of WNT4 mRNA in the chicken oviduct, in situ
hybridization analysis was performed (Figure 1C). The WNT4
mRNA was most abundant in stromal cells and luminal epithelia
(LE) of the isthmus and the shell gland, respectively. However,
little or no mRNA was detected in the infundibulum and the
magnum of the chick oviduct.
Expression and localization of WNT4 in the chicken
oviduct at different stages of the laying cycle
We previous reported spatial and temporal changes in gene
expression in the oviduct of laying hens at different stages of the
laying cycle [8]. In order to detect cell-specific localization of
WNT4 mRNA in the chicken oviduct between 3 h and 20 h after
ovulation, RT-PCR, quantitative PCR and in situ hybridization
analyses were performed. As illustrated in Figure 1D, RT-PCR
analysis detected the highest level of WNT4 mRNA expression at
3 h post-ovulation in the shell gland and lowest expression at 20 h
post-ovulation in the shell gland, but little or no detectable WNT4
mRNA in the magnum at either time point. In addition,
quantitative PCR analysis revealed that expression of WNT4
mRNA was 3.32-fold (P,0.001) at 3 h than at 20 h post-ovulation
in the shell gland, but changes in expression of WNT4 mRNA
were not different between 3 h and 20 h post-ovulation in the
magnum (Figure 1E). Consistent with these results, in situ
hybridization analyses indicated that WNT4 mRNA was predom-
inantly localized to the glandular epithelium (GE) of the shell
gland at 3 h post-ovulation and it was also detected to a lesser
extent in LE of the shell gland at both time points (Figure 1F).
However, there is either no or very little expression of WNT4 in
the magnum.
Effects of DES on WNT4 expression in the chicken oviduct
Cell-specific expression of WNT4 mRNA in the oviduct of
mature hens suggested regulation by estrogen during development
of the chicken oviduct. Because diethylstilbestrol (DES) is a
synthetic estrogen that binds to estrogen receptors with similar
effect of the natural estrogen, 17b-estradiol [1,9,10], we deter-
mined effects of DES and reported that DES regulates growth,
development and cytodifferentiation of the immature chick
oviduct [9]. Likewise, we examined the effects of DES on
expression of WNT4 mRNA in the chicken oviduct in the present
study. As illustrated in Figure 2A and 2B, expression of WNT4
mRNA increased in DES-treated oviducts as compared with
untreated oviducts. Further, quantitative PCR analysis confirmed
that WNT4 expression increased 1.6-fold (P,0.05) in DES-treated
as compared to control oviducts (Figure 2C). In addition, DES
treatment stimulated 4.1- and 12.3-fold increases (P,0.001) in
WNT4 mRNA in the isthmus and the shell gland, respectively
(Figure 2D). To determine localization of WNT4 mRNA in chick
oviducts treated with DES, in situ hybridization analysis was used
to reveal thatWNT4 mRNA is expressed predominantly expressed
in GE of the isthmus and the shell gland (Figure 2E). There was
little or no detectable WNT4 mRNA in the infundibulum and
magnum.
Post-transcriptional regulation of microRNA affecting
WNT4
To demonstrate the possibility that expression of WNT4 is
affected through the post-transcriptional regulation by miRNAs,
we performed a miRNA target validation assay. We identified
potential miRNA binding sites within the 39-UTR of the WNT4
gene using the miRNA target prediction database (miRDB;
http://mirdb.org/miRDB/) which revealed only one putative
binding site for miR-1786. Therefore, we determined whether miR-
1786 influenced expression of the WNT4 gene via its 39-UTR. As
illustrated in Figures 3C and 3D, the expression level of GFP-
expressing cells decreased 33.5% (P,0.05) in the presence of miR-
1786, as compared with control values based on FACS and
fluorescence microscopy analyses. In addition, miR-1786 expres-
sion was reduced 75% (P,0.01) in the DES-treated oviducts as
compared to untreated oviducts of chicks through miRNA-specific
quantitative RT-PCR analysis (Figure 3E). These results reveal
that miR-1786 regulates WNT4 expression post-transcriptionally in
vivo by binding directly to the WNT4 transcript.
Differential expression of WNT4 between normal and
cancerous ovaries of hens
The laying hen is a unique animal model for study of human
epithelia-derived ovarian cancer research. This is because they
spontaneously develop ovarian cancer of the surface epithelium of
the ovaries at a high rate and are useful for development of
biomarkers for detection and early diagnosis of ovarian cancer, as
well as for discovery of anti-cancer drugs/biomaterials [11]. There
is evidence that epithelial cell-derived ovarian cancer (EOC) in
women may originate from epithelial cells of the oviduct [12,13].
Likewise, in chickens, Trevino et al [14] reported that about 50%
of up-regulated genes in EOC of laying hens are oviduct-
associated genes. In addition, we reported that several estrogen-
stimulated genes, including serpin peptidase inhibitor, clade B, member
11 (SERPINB11) [15], SERPINB3 [16], cathepsin B (CTSB) [17], S-
adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) [18], alpha 2
macroglobulin (A2M) [19], secreted phosphoprotein 1 (SPP1) [20],
pleiotrophin (PTN) [21], several cell cycle genes [22] and beta-defensin
11 (AvBD-11) [23] in the chicken oviduct are detected predom-
inantly in glandular epithelial cells of ovaries from laying hens with
ovarian adenocarcinoma. Furthermore, there are several reports
that over-expression of WNT4 is induced by its mutated regulator
genes such as beta-catenin and GSK3B or aberrant expression of
miRNAs in various cancer types [24,25,26]. Therefore, we
hypothesized that expression patterns for WNT4 would differ
between normal and cancerous ovarian tissues from laying hens
and then determined whether cell-specific WNT4 expression was
detectable in ovaries of laying hens with ovarian cancer. As
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illustrated in Figure 4A, quantitative PCR revealed that WNT4
mRNA increased 3.35-fold (P,0.05) in cancerous ovaries as
compared with normal ovaries of laying hens. Further, WNT4
mRNA was localized predominantly to GE of cancerous ovaries,
but not in any other cells including stroma and blood vessel
(Figure 4B). However, WNT4 mRNA was not detected in normal
ovaries.
Discussion
In the present study, we demonstrated that the WNT4 gene is
expressed in the isthmus and shell gland of the chicken oviduct in
response to estrogen. In addition, expression of WNT4 is post-
transcriptionally regulated by direct binding of its specific
microRNA (miR-1786). Moreover, we found increased expression
of WNT4 in cancerous ovaries of laying hens that increased with
age. These results support our hypothesis that WNT4 affects
growth, differentiation and development of the chicken oviduct,
and provide novel insights and concepts for further study of
Figure 1. Expression and localization of WNT4 in the chicken oviduct. Both RT-PCR [A] and quantitative PCR [B] analyses were performed
using cDNA templates from each segment of the chicken oviduct. These experiments were conducted in triplicate and normalized to control ACTB
expression. [C] In situ hybridization analysis for cell-specific changes in expression of WNT4 in the each segment of the chicken oviduct. Both RT-PCR
[D] and quantitative PCR [E] analyses were performed using cDNA templates from the magnum and the shell gland segment at 3 h and 20 h after
ovulation. [F] In situ hybridization analysis for cell-specific changes in expression of WNT4 in the magnum and the shell gland at 3 h and 20 h after
ovulation. Legend: ST, stromal cells; GE, glandular epithelium; LE, luminal epithelium. Scale bar represents 50 mm (the first and the third horizontal
panels) and 20 mm (the second horizontal panel). The tissue samples were from oviducts of 1- to 2- year-old female laying hens (n = 5). The asterisks
denote statistically significant differences (***P,0.001 and **P,0.01).
doi:10.1371/journal.pone.0065935.g001
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WNT4-related physiological processes in the laying cycle of hens
and in ovarian carcinogenesis.
Among the WNT family members, WNT4 is a growth factor
involved in development of a number of organs such as kidney,
mammary gland and adrenal gland, as well as development of the
reproductive tract inmammals [4]. Inmice,Wnt4 is highly expressed
in the female reproductive tract with different expression patterns
depending on stage of the estrous cycle and it is also involved in
stromal cell proliferation and differentiation in the uterus which is
required for implantation and decidualization during early preg-
nancy [5]. In addition,Wnt42/2mice have an abnormal phenotype
with respect to postnatal uterine development which renders female
mice subfertile due to defects in implantation of blastocyst and
subsequent survival, differentiation, and responsiveness to proges-
terone signaling by uterine stromal cells [5,6]. However, WNT4
expression and function in the reproductive tract female chickens
has not been reported previously.
Recently, Nicol and colleagues reported that WNT4 protein
was highly conserved throughout vertebrate evolution [27]. The
results also revealed that chicken WNT4 is likely to have similar
physiological functions as for other vertebrate species. In the
present study, we demonstrated expression of WNT4 in glandular
(GE) and luminal epithelia (LE) of the isthmus and shell gland of
the chicken oviduct (Figure 1). During passage of the egg through
Figure 2. Effect of DES on tissue-specific expression of chicken WNT4. Both RT-PCR [A and B] and quantitative PCR [C and D] analyses were
performed using cDNA templates from DES-treated and untreated oviducts. These experiments were conducted in triplicate and normalized to
control ACTB expression. [E] In situ hybridization analyses revealed cell-specific expression of WNT4 mRNA in oviducts of DES-treated and untreated
chicks. Cross-sections of the four segments of chicken oviduct (infundibulum, magnum, isthmus, and shell gland) from chicks treated with DES or
vehicle were hybridized with antisense or sense chicken WNT4 cRNA probes. Legend: GE, glandular epithelium LE, luminal epithelium. Scale bar
represents 50 mm (the first and the third horizontal panel) and 20 mm (the second horizontal panel). The tissue samples were used from 37-day-old
chick oviducts (n = 5). The asterisks denote statistically significant differences (***P,0.001 and *P,0.05).
doi:10.1371/journal.pone.0065935.g002
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the oviduct, several layers of egg shell membranes that surround
the yolk and the white are added sequentially as the egg mass
passes through successive sections of the oviduct [28]. About 2 to
3 h after ovulation, the fertilized egg, with secretion of egg-white
proteins including albumen from the magnum, passes into the
isthmus which secretes various components of the soft shell
membranes such as keratin-like protein, and types I, V and X
collagens [29,30]. The formation of the egg shell involving calcium
deposition (approximately 5 to 6 g of calcium carbonate) is
completed in the shell gland of the oviduct within 17 to 20 h after
ovulation [28]. These results indicate that WNT4 may have roles
Figure 3. In vitro target assay of miR-1786 on WNT4 transcript. [A] Diagram of miR-1786 binding site in the 39-UTR of the WNT4 gene. [B]
Expression vector maps for eGFP with the 39-UTR of WNT4 and Ds-Red with miR-1786. The 39-UTR of the WNT4 transcript was subcloned between the
eGFP gene and the polyA tail to generate the fusion construct of the GFP transcript following the miRNA target 39-UTR (pcDNA-eGFP-39UTR) (upper
panel) and miRNA expression vector was designed to co-express DsRed and miRNA (pcDNA-DsRed-miRNA) (lower panel). [C and D] After co-
transfection of pcDNA-eGFP-39UTR for the WNT4 transcript and pcDNA-DsRed-miRNA for the miR-1786, the fluorescence signals of GFP and DsRed
were detected using FACS [C] and fluorescent microscopy [D]. [E] Quantitative expression of miR-1786 between untreated and DES-treated oviducts
of chicks was analyzed by qRT-PCR. This experiment was normalized to control U6 snRNA expression. The asterisk denotes statistically significant
differences (**P,0.01).
doi:10.1371/journal.pone.0065935.g003
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in the oviductal epithelial cells of the chicken during egg formation
and oviposition.
Results of the present study also demonstrated that DES
stimulates WNT4 expression in GE of the isthmus and shell gland
of the oviduct of developing chick reproductive tract (Figure 2).
Indeed, DES induces massive growth of the juvenile oviduct and
induces cytodifferentiation of epithelial cells into tubular gland
cells, goblet cells, and ciliated cells [1]. In mice, expression of the
Wnt4 gene is regulated by estrogen during development of the
uterus [5,6]. There are changes in gene expression in the chick
oviduct after exposure to DES [9] as DES binds strongly to
estrogen receptor alpha (ESR1) to act as an agonist with effects
similar to those induced by 17b-estradiol [1]. Thus, our results
indicate that DES increases expression of WNT4 in a tissue- and
cell-specific manner that is coordinate with development, differ-
entiation and function of the various anatomical components of
the chicken oviduct.
MicroRNAs (miRs) are short RNA molecules that control
expression of certain genes by regulating mRNA stability and
translation [31]. In chickens, hundreds of miRs have been
identified, but functions are known for only a few miRs. In this
study, we performed a miR target validation assay to determine
whether specific miRs bind to the 39-UTR of WNT4 gene with the
potential to affect transcription. As illustrated in Figure 3, co-
transfection of eGFP-WNT4 39-UTR and DsRed-miR-1786
decreased the ratio of GFP-positive cells and GFP fluorescence
density when compared to untreated control cells. Moreover, as
shown in Figure 3E, miR-1786 expression decreased in vivo in
response to DES as compared to expression in oviducts of control
chicks. These result revealed that WNT4 expression was
influenced in vitro via its 39-UTR which binds miR-1786 directly
and also in vivo wherein DES-mediated a decrease in miR-1786.
Consequently, we found that miR-1786 inhibits expression of
WNT4 in laying hens by regulating various post-transcriptional
events that likely affect cellular processes in development,
differentiation and oncogenesis in the reproductive tract of laying
hens. However, further study is required to better understand its
regulatory mechanism.
Ovarian cancer is a lethal gynecological malignancy and the
overall 5-year survival rate from this disease is only 30 to 40%
because most cases of the ovarian cancer are not detected at an
early stage which makes it difficult to apply any type of therapy
[32]. To overcome this problem, various animal models have been
developed, but they have not proven to be as useful as the laying
hen. However, the laying hen is recognized as the most
appropriate animal model because they spontaneously develops
ovarian cancer of the surface epithelium at a high rate as they age,
as also occurs in women [11]. Indeed, CTSB [17], SERPINB11
[15], A2M [19], and PTN [21] are genes that we reported to be
most abundant in the GE of ovarian cancers in laying hens. In the
present study, we found that WNT4 is highly expressed in the GE
of cancerous as compared with normal ovaries of laying hens.
These results strongly support the idea that the WNT4 expression
is associated with initiation and development of human ovarian
cancer and even more so as the individual ages [33]. Therefore, we
suggest that WNT4 is likely to be involved in development of
ovarian cancer as laying hen undergo aging.
In summary, results of this study demonstrated that WNT4 is an
estrogen-regulated gene during growth, development and differ-
entiation of the chicken oviduct and that is likely plays a critical
role in abnormal growth and function of cancerous ovarian cells of
laying hens. These results provide new insights into the roles of
WNT4 with respect to its hormonal regulation and post-
transcriptional regulation of its expression in the oviduct and in
ovarian tumors of laying hen.
Materials and Methods
Experimental Animals and Animal Care
The experimental use of chickens for this study was approved by
the Institute of Laboratory Animal Resources, Seoul National
University (SNU-070823-5). White Leghorn (WL) laying hens
were subjected to standard management practices at the Univer-
sity Animal Farm, Seoul National University, Korea. All hens
were exposed to a light regimen of 15 h light and 9 h dark with ad
libitum access to feed and water.
Figure 4. Expression and localization of WNT4 between normal
and cancerous ovaries. [A] Quantitative PCR analysis was performed
using cDNA templates from normal and cancerous ovaries. [B] In situ
hybridization analyses revealed cell-specific expression of WNT4 mRNA
between normal and cancerous ovary. Legend: GE, glandular epithe-
lium. Scale bar represents 50 mm (the first and the third horizontal
panel) and 20 mm (the second horizontal panel). The tissue samples
were from normal and cancerous ovaires of 2- to 3- year-old laying hens
(n = 5). The asterisks denote statistically significant differences
(*P,0.05).
doi:10.1371/journal.pone.0065935.g004
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Tissue Samples
Study One. Following euthanasia of mature WL hens, tissue
samples were collected from oviduct of 1- to 2- year-old females
(n = 5). The collected samples were either frozen or fixed in 4%
paraformaldehyde for further analyses. Frozen tissue samples were
cut into 5- to 7-mm pieces, frozen in liquid nitrogen vapor, and
stored at 280uC. The other samples were cut into 10 mm pieces
and fixed in fresh 4% paraformaldehyde in PBS (pH 7.4). After
24 h, fixed tissues were changed to 70% ethanol for 24 h and then
dehydrated and embedded in Paraplast-Plus (Leica Microsystems,
Wetzlar, Germany). Paraffin-embedded tissues were sectioned at
5 mm.
Study Two. Female chicks were identified by PCR analysis
using W chromosome-specific primer sets [34]. Treatment with
DES and recovery of the oviduct (n = 5) were conducted as reported
previously [10]. Briefly, a 15 mg DES pellet was implanted
subcutaneously in the abdominal region of 1-week-old female
chicks for 10 days. The DES pellet was removed for 10 days, and
then a 30 mg dose of DES was administered for 10 additional days.
Five 37-day-old chicks in each group were euthanized using 60%–
70% carbon dioxide. The collected samples were either frozen or
fixed in 4% paraformaldehyde for further analyses. Paraffin-
embedded tissues were sectioned at 5 mm.
Study Three. Hens (n = 5 per time point) were euthanized at
either 3 h or 20 h after ovulation using 60%–70% carbon dioxide.
Samples of the magnum and the shell gland of oviducts from each
hen were collected at each time point. Sampling of magnum and
shell gland was at the middle of each tissue to prevent mixing with
another tissue such as the infundibulum and isthmus. The tissue
samples of similar size were: 1) removed and placed in Optimal
Cutting Temperature (OCT) compound (Miles, Oneonta, NY); 2)
frozen in liquid nitrogen and stored at 280uC; 3) fixed in freshly
prepared 4% paraformaldehyde in PBS (pH 7.4); or 4) frozen
immediately in liquid nitrogen and stored at280uC until analyzed.
After 24 h, tissues fixed in 4% paraformaldehyde were changed to
70% ethanol for 24 h and then dehydrated and embedded in
Paraplast-Plus (Leica Microsystems, Wetzlar, Germany).
Study Four. A total 136 chickens (88 chickens aged over
36 months and 48 chickens aged over 24 months), which had
completely stopped laying eggs were euthanized for biopsy and
cancerous (n = 10) ovaries were collected. As a control, normal
(n = 5) ovaries were also collected from egg-laying hens. We
examined the tumor stage in 10 chickens with cancerous ovaries
using characteristic features of chicken ovarian cancer [15,35].
Three hens had stage III disease as ovarian tumor cells had
metastasized to the gastrointestinal (GI) tract and liver surface with
profuse ascites in the abdominal cavity. Five hens had tumor cells
spread to distant organs including liver parenchyma, lung, GI tract
and oviduct with profuse ascites, indicating stage IV disease. Two
hens had stage I disease as tumors were limited to their ovaries.
The collected samples were fixed in 4% paraformaldehyde for
further analyses. After 24 h, fixed tissues were changed to 70%
ethanol for 24 h and then dehydrated and embedded in Paraplast-
Plus (Leica Microsystems, Wetzlar, Germany). Paraffin-embedded
tissues were sectioned at 5 mm and stained with hematoxylin and
eosin. Epithelial ovarian cancers in chickens were classified based
on the cellular subtypes and patterns of cellular differentiation with
reference to ovarian malignant tumor types in humans [35].
RNA Isolation
Total cellular RNA was isolated from frozen tissues using Trizol
reagent (Invitrogen, Carlsbad, CA) according to manufacturer’s
recommendations. The quantity and quality of total RNA was
determined by spectrometry and denaturing agarose gel electro-
phoresis, respectively.
RT-PCR Analysis
The expression of WNT4 mRNA in chicken organs including
the oviduct, ovary and cancerous ovary was assessed using RT-
PCR as described previously [36]. The cDNA was synthesized
from total cellular RNA (2 ug) using random hexamer (Invitrogen,
Carlsbad, CA) and oligo (dT) primers and AccuPowerH RT
PreMix (Bioneer, Daejeon, Korea). The cDNA was diluted (1:10)
in sterile water before use in PCR. For WNT4, the sense primer
(59- GGA GTG CCA GTA CCA ATT CC -39) and antisense
primer (59- CGT CGA ATT TCT CCT TCA GC -39) amplified a
491-bp product. For ACTB (housekeeping gene), the sense primer
(59- GGC TGT GCT GTC CCT GTA TG -39) and antisense
primer primer (59- ACC CAA GAA AGA TGG CTG GA -39)
amplified a 394-bp product. For Ribosomal protein 4 (RPL4)
(housekeeping gene), the sense primer (59- GGT ACT GGG
AGA GCT GTT GC -39) and antisense primer primer (59- CCG
GAA AGC TCT AAT GAT GC -39) amplified a 465-bp product.
The primers, PCR amplification and verification of their
sequences were conducted as described previously [36]. PCR
amplification was conducted using approximately 60 ng cDNA as
follows: (1) 95uC for 3 min; (2) 95uC for 20 sec, 60uC for 40 sec
and 72uC for 1 min for 35 cycles; and (3) 72uC for 10 min. After
PCR, equal amounts of reaction product were analyzed using a
1% agarose gel, and PCR products were visualized using ethidium
bromide staining. The amount of DNA present was quantified by
measuring the intensity of light emitted from correctly sized bands
under ultraviolet light using a Gel DocTM XR+ system with Image
LabTM software (Bio-Rad).
Quantitative RT-PCR Analysis
Total RNA was extracted from each segment of the oviduct and
the ovary using TRIzol (Invitrogen) and purified using an RNeasy
Mini Kit (Qiagen). Complementary DNA was synthesized using a
SuperscriptH III First-Strand Synthesis System (Invitrogen). Gene
expression levels were measured using SYBRH Green (Biotium,
Hayward, CA, USA) and a StepOnePlus
TM
Real-Time PCR
System (Applied Biosystems, Foster City, CA, USA). The ACTB
and RLP4 genes were analyzed simultaneously as reporter genes
and used for normalization of data. These experiments were
performed in triplicate. For WNT4, the sense primer (59- GGA
GTG CCA GTA CCA ATT CC -39) and antisense primer (59-
AGA GAT GGC GTA GAC GAA CG -39) amplified a 121-bp
product. For ACTB, the sense primer (59- CCC ATC TAT GAA
GGC TAC GC -39) and antisense primer primer (59- CAC GCA
CAA TTT CTC TCT CG -39) amplified a 142-bp product. For
RLP4, the sense primer (59- GAA GAT TCA CCG CAG AGT
CC -39) and antisense primer primer (59- GTT TTT GAT TCT
GGG CAT GG -39) amplified a 125-bp product. The PCR
conditions were 94uC for 3 min, followed by 40 cycles at 94uC for
20 sec, 60uC for 40 sec, and 72uC for 1 min using a melting curve
program (increasing the temperature from 55uC to 95uC at 0.5uC
per 10 sec) and continuous fluorescence measurement. ROX dye
(Invitrogen) was used as a negative control for the fluorescence
measurements. Sequence-specific products were identified by
generating a melting curve in which the CT value represented
the cycle number at which a fluorescent signal was significantly
greater than background, and relative gene expression was
quantified using the 2–DDCT method [37]. The 2–DDCT method is
also known as the comparative CT method. WNT4 expression was
calculated using the following equation: DDCT = DCT, WNT4 -
CT, reference gene. These CT value was normalized to the
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endogenous reference genes. For comparing WNT4 expression
between untreated and DES-treated oviducts in chickens, the
relative quantification of gene expression was normalized to the
CT value of the untreated oviduct.
In Situ Hybridization Analysis
Location of WNT4 mRNA in sections (5 mm) of chicken
oviducts and ovaries was determined by in situ hybridization
analysis as described previously [21]. Briefly, for hybridization
probes, PCR products were generated from cDNA primers used
for RT-PCR analysis. The products were gel-extracted and cloned
into pGEM-T vector (Promega). After verification of the
sequences, plasmids containing gene sequences were amplified
with T7- and SP6-specific primers (T7:59-TGT AAT ACG ACT
CAC TAT AGG G-39; SP6:59-CTA TTT AGG TGA CAC TAT
AGA AT-39). Then digoxigenin (DIG)-labeled RNA probes were
transcribed using a DIG RNA labeling kit (Roche Applied
Science, Indianapolis, IN). Tissues were collected, fixed in 4%
paraformaldehyde, embedded in paraffin, sectioned at 5 mm and
sections placed on APES-treated (silanized) slides. The sections
were then deparaffinized in xylene and rehydrated to diethylpyr-
ocarbonate (DEPC)-treated water through a graded series of
alcohol. The sections were treated with 1% Triton X-100 in PBS
for 20 min and washed twice in DEPC-treated PBS. The sections
were then digested in 5 mg/ml Proteinase K (Sigma) in TE buffer
(100 mM Tris-HCl, 50 mM EDTA, pH 8.0) at 37uC. After post-
fixation in 4% paraformaldehyde, sections were incubated twice
for 5 min each in DEPC-treated PBS and incubated in TEA
buffer [0.1M triethanolamine containing 0.25% (v/v) acetic
anhydride]. The sections were incubated in a prehybridization
mixture containing 50% formamide and 4X standard saline citrate
(SSC) for at least 10 min at room temperature. After prehybri-
dization, the sections were incubated with a hybridization mixture
containing 40% formamide, 4X SSC, 10% dextran sulfate sodium
salt, 10 mM DTT, 1 mg/ml yeast tRNA, 1mg/ml salmon sperm
DNA, 0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.2mg/ml
RNase-free bovine serum albumin and denatured DIG-labeled
cRNA probe overnight at 42uC in a humidified chamber. After
hybridization, sections were washed for 15 min in 2X SSC at
37uC, 15 min in 1X SSC at 37uC, 30 min in NTE buffer (10 mM
Tris, 500 mM NaCl and 1mM EDTA) at 37uC and 30 min in
0.1X SSC at 37uC. After blocking with 2% normal sheep serum
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA), the sections
were incubated overnight with sheep anti-DIG antibody conju-
gated to alkaline phosphatase (Roche, Indianapolis, IN). The
signal was visualized by exposure to a solution containing 0.4 mM
5-bromo-4-chloro-3-indolyl phosphate, 0.4 mM nitroblue tetrazo-
lium, and 2 mM levamisole (Sigma Chemical Co., St. Louis, MO).
MicroRNA Target Validation Assay
The 39-UTR of WNT4 was subcloned into pcDNA3eGFP
(Clontech, Mountain View, CA) to generate the eGFP-miRNA
target 39-UTR fusion construct. For the dual fluorescence reporter
assay, the fusion constructs containing the DsRed gene and miR-
1786, were designed to be co-expressed under control of the CMV
promoter. Both constructs were co-transfected into 293FT cells
using the calcium phosphate method. When the DsRed-miRNA is
expressed and binds to the target site of the 39-UTR downstream
of the GFP transcript, green fluorescence intensity decreases due
to degradation of the GFP transcript. At 48 h post-transfection,
dual fluorescence was detected by fluorescence microscopy and
calculated by FACSCalibur flow cytometry (BD Biosciences). For
flow cytometry, the cells were fixed in 4% paraformaldehyde and
analyzed using FlowJo software (Tree Star Inc., Ashland, OR).
Statistical Analyses
All quantitative data were subjected to analysis of variance
(ANOVA) according to the general linear model (PROC-GLM) of
the SAS program (SAS Institute, Cary, NC). All tests of
significance were performed using the appropriate error terms
according to the expectation of the mean square for error. Data
are presented as mean6 SEM unless otherwise stated. Differences
in the variance between untreated and DES-treated oviducts were
analyzed using the F test, and differences in the means were
subjected to Student’s t test. Differences were considered
significant at P,0.05.
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